Ibrutinib Plus Venetoclax for First-line Treatment of Chronic Lymphocytic Leukemia

American Medical Association, JAMA Oncology, 8(7), p. 1213, 2021

Journal article published in 2021 by Nitin Jain, Michael Keating, Philip Thompson, Alessandra Ferrajoli, Jan A. Burger, Gautam Borthakur, Koichi Takahashi, Zeev Estrov, Koji Sasaki, Nathan Fowler, Tapan Kadia, Marina Konopleva, Yesid Alvarado, Musa Yilmaz, Courtney DiNardo and other authors.

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving forbidden

Published version: archiving forbidden

Policy details

Data provided by